Papers

3

Total Citations

19

H-Index

2

About

Arturo Chiti is a leading figure in the surgical and radiotherapeutic management of prostate cancer, with a focus on precision medicine and minimally invasive techniques. His major contributions center on optimizing radioguided surgery (RGS) using PSMA-targeted tracers to improve the detection of lymph node invasion during robot-assisted procedures. In his most cited work, a prospective phase II study, he established the optimal target-to-background ratio for identifying positive nodes, a critical step toward standardizing PSMA-RGS and reducing unnecessary extended pelvic dissections. With over 13 citations since 2024, this work is already shaping intraoperative decision-making. Chiti also pioneers ultra-hypofractionated radiotherapy, as seen in his PRO-FAST protocol—a single-fraction, urethral-sparing, HDR-like robotic SBRT approach that compresses treatment into one day. This innovation addresses a major patient need for shorter, more convenient therapy without compromising efficacy. His research bridges surgical and radiation oncology, offering integrated, patient-centered solutions. Chiti’s work is widely cited and increasingly adopted, marking him as a key innovator in the next generation of prostate cancer care.

Research Focus

Key Achievements

2
H-Index
3
Papers
19
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study
13 citations · 2024
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 43
🏛 Institutions: Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago